Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK500703PMID: 29999762
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 58069-82-2
Drug Levels and Effects
Summary of Use during Lactation
Information in this record refers to the use of urea C13 as a diagnostic agent. Because carbon 13 is not radioactive, no special precautions are required for nursing mothers.
Drug Levels
Carbon 13 is not radioactive.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Urea C 13
CAS Registry Number
58069-82-2
Drug Class
- Breast Feeding
- Carbon Isotopes
- Diagnostic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Urea C 14.[Drugs and Lactation Database (...]Review Urea C 14.. Drugs and Lactation Database (LactMed®). 2006
- Review [C13 urea breath test in the diagnosis of Helicobacter pylori infection in the gastric mucosa. Validation of the method].[Rev Esp Enferm Dig. 1996]Review [C13 urea breath test in the diagnosis of Helicobacter pylori infection in the gastric mucosa. Validation of the method].Pérez García JI, Pajares García JM, Jiménez Alonso I. Rev Esp Enferm Dig. 1996 Mar; 88(3):202-8.
- Gastro-oesophageal reflux disease in general practice. Utility and acceptability of Infai C13-urea breath test has been shown.[BMJ. 2002]Gastro-oesophageal reflux disease in general practice. Utility and acceptability of Infai C13-urea breath test has been shown.Alberti H. BMJ. 2002 Feb 23; 324(7335):485-6.
- Correlation between Quantitative (13)C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort.[Gastroenterol Res Pract. 2018]Correlation between Quantitative (13)C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort.Boltin D, Levi Z, Perets TT, Schmilovitz-Weiss H, Gingold-Belfer R, Dickman R, Dotan I. Gastroenterol Res Pract. 2018; 2018:5439539. Epub 2018 Nov 13.
- Review Carbamide Peroxide.[Drugs and Lactation Database (...]Review Carbamide Peroxide.. Drugs and Lactation Database (LactMed®). 2006
- Urea C 13 - Drugs and Lactation Database (LactMed®)Urea C 13 - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...